📰 Jon Koff News
Jon Koff News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jon Koff. Real-time updates on events, politics, business and more.
September 21, 2023
Jackson Parrott ’27 will dine with Salovey — his prize for winning the junior class council’s fundraiser raffle for cystic fibrosis research.
March 3, 2022
/PRNewswire/ -- Felix Biotechnology — a biopharmaceutical company focused on developing first-in-class, durable, antibacterial therapies to treat chronic...
March 3, 2022
/PRNewswire/ -- Felix Biotechnology — a biopharmaceutical company focused on developing first-in-class, durable, antibacterial therapies to treat chronic...
February 15, 2022
The Center for Phage Biology and Therapy at Yale held its launch event on Thursday, January 27, 2022, by hosting a panel discussion on the context of the
January 10, 2022
/PRNewswire/ -- Today Quantum Leap Healthcare Collaborative (QLHC), sponsor of the I-SPY COVID Trial, announced that the Pulmozyme® (dornase alfa) arm of the...
January 7, 2021
Share this article Share this article SAN FRANCISCO, Jan. 7, 2021 /PRNewswire/ -- Felix Biotechnology today announced the initiation of CYPHY, a Phase 1/2 investigator-initiated single center trial at Yale University for targeted phage therapy YPT-01 in the treatment of chronic P. aeruginosa infections in cystic fibrosis. This double-blind, placebo-controlled study ( NCT 04684641) will assess the safety and efficacy of YPT-01 added to standard antimicrobial therapy in 36 patients. CYPHY wi...